Qingxuan Zeng

Statistics

Publications

Citations

868

H-Index

Active since

2017

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Qingdao Women and Children's Hospital

Qingdao University

Zhejiang Hospital

Nanchang University

Qingxuan Zeng is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in pharmacology, medicinal chemistry, and life sciences.

Publications per year

2017–2024

Publications

Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5

Yang Liu, Xiaojia Liu, Na Zhang et al. · Acta Pharmaceutica Sinica B · 2020 · 224 citations · Full text

Medicine, Oncology, Pharmacology +17

Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity

Qingxuan Zeng, Hongbin Deng, Yinghong Li et al. · Journal of Medicinal Chemistry · 2020 · 103 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects

Wei Wei, Qingxuan Zeng, Yan Wang et al. · Acta Pharmaceutica Sinica B · 2022 · 85 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1

Yanxiang Wang, Weiqiang Pang, Qingxuan Zeng et al. · European Journal of Medicinal Chemistry · 2017 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1

Na Zhang, Yueying Dou, Lu Liu et al. · EBioMedicine · 2019 · 74 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 19